Is Immunotherapy Appropriate Here?Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.
As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.